Published in Am Heart J on May 04, 2012
The role of concentration-effect relationships in the assessment of QTc interval prolongation. Br J Clin Pharmacol (2015) 1.09
Drug-induced QT interval prolongation: does ethnicity of the thorough QT study population matter? Br J Clin Pharmacol (2013) 1.03
Exenatide at therapeutic and supratherapeutic concentrations does not prolong the QTc interval in healthy subjects. Br J Clin Pharmacol (2013) 0.86
Electrocardiographic effects of class 1 selective histone deacetylase inhibitor romidepsin. Cancer Med (2015) 0.85
Are women more susceptible than men to drug-induced QT prolongation? Concentration-QTc modelling in a phase 1 study with oral rac-sotalol. Br J Clin Pharmacol (2014) 0.82
QT/RR curvatures in healthy subjects: sex differences and covariates. Am J Physiol Heart Circ Physiol (2013) 0.78
Dabigatran does not prolong the QT interval with supratherapeutic exposure: a thorough QT study in healthy subjects. Clin Drug Investig (2013) 0.76
QT is longer in drug-free patients with schizophrenia compared with age-matched healthy subjects. PLoS One (2014) 0.75
Levofloxacin-Induced QTc Prolongation Depends on the Time of Drug Administration. CPT Pharmacometrics Syst Pharmacol (2016) 0.75
Analysis of the effects on the QT interval of a gatifloxacin-containing regimen versus standard treatment of pulmonary tuberculosis. Antimicrob Agents Chemother (2017) 0.75
Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study. Lancet Infect Dis (2011) 3.85
Work stress and coronary heart disease: what are the mechanisms? Eur Heart J (2008) 3.56
Risk of COPD from exposure to biomass smoke: a metaanalysis. Chest (2010) 3.46
The impact of drug-induced QT interval prolongation on drug discovery and development. Nat Rev Drug Discov (2003) 3.19
Does autonomic function link social position to coronary risk? The Whitehall II study. Circulation (2005) 3.12
Lin28 enhances tissue repair by reprogramming cellular metabolism. Cell (2013) 3.08
Concentration-QT relationships play a key role in the evaluation of proarrhythmic risk during regulatory review. J Clin Pharmacol (2008) 3.06
Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility--consensus guideline by International Society for Holter and Noninvasive Electrocardiology. J Am Coll Cardiol (2011) 3.00
Enterovirus 71 outbreak in the People's Republic of China in 2008. J Clin Microbiol (2009) 2.98
Influence of threonine metabolism on S-adenosylmethionine and histone methylation. Science (2012) 2.98
A role for Lin28 in primordial germ-cell development and germ-cell malignancy. Nature (2009) 2.88
Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study. Lancet (2006) 2.75
Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol (2003) 2.71
Impact of pharmacometric analyses on new drug approval and labelling decisions: a review of 198 submissions between 2000 and 2008. Clin Pharmacokinet (2011) 2.67
Analysis of thrombocyte development in CD41-GFP transgenic zebrafish. Blood (2005) 2.65
Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med (2007) 2.62
Identification of adult nephron progenitors capable of kidney regeneration in zebrafish. Nature (2011) 2.42
Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol (2007) 2.28
Memory effect in magnetic nanowire arrays. Adv Mater (2011) 2.11
Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med (2007) 2.09
Drug-induced torsades de pointes and implications for drug development. J Cardiovasc Electrophysiol (2004) 2.05
Lin28 sustains early renal progenitors and induces Wilms tumor. Genes Dev (2014) 1.87
Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology Consensus. J Am Coll Cardiol (2008) 1.86
Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials. Eur Heart J (2005) 1.84
Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing loss. Nat Genet (2005) 1.80
Critical assessment of QSAR models of environmental toxicity against Tetrahymena pyriformis: focusing on applicability domain and overfitting by variable selection. J Chem Inf Model (2008) 1.79
Improving the precision of QT measurements. Cardiol J (2011) 1.74
Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial. Hypertension (2010) 1.74
Bivariate phase-rectified signal averaging for assessment of spontaneous baroreflex sensitivity: pilot study of the technology. J Electrocardiol (2010) 1.70
Assessing proarrhythmic potential of drugs when optimal studies are infeasible. Am Heart J (2009) 1.66
Characterization of embryonic globin genes of the zebrafish. Dev Biol (2003) 1.65
Dyslipidemia and atherosclerosis induced by chronic intermittent hypoxia are attenuated by deficiency of stearoyl coenzyme A desaturase. Circ Res (2008) 1.61
Chronic intermittent hypoxia predisposes to liver injury. Hepatology (2007) 1.57
Prevalent low-frequency oscillation of heart rate: novel predictor of mortality after myocardial infarction. Circulation (2004) 1.52
Effects of moderate and vigorous physical activity on heart rate variability in a British study of civil servants. Am J Epidemiol (2003) 1.52
Coxsackievirus A21, enterovirus 68, and acute respiratory tract infection, China. Emerg Infect Dis (2012) 1.52
A double-blind, randomized, parallel, placebo-controlled study examining the effect of cross-linked polyelectrolyte in heart failure patients with chronic kidney disease. Eur J Heart Fail (2012) 1.50
Chronic intermittent hypoxia and acetaminophen induce synergistic liver injury in mice. Exp Physiol (2008) 1.48
Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis (2009) 1.48
Repolarization abnormality for prediction of all-cause and cardiovascular mortality in American Indians: the Strong Heart Study. J Cardiovasc Electrophysiol (2005) 1.47
Individual patterns of dynamic QT/RR relationship in survivors of acute myocardial infarction and their relationship to antiarrhythmic efficacy of amiodarone. J Cardiovasc Electrophysiol (2004) 1.46
QSAR modeling of the blood-brain barrier permeability for diverse organic compounds. Pharm Res (2008) 1.46
QT-RR relationship in healthy subjects exhibits substantial intersubject variability and high intrasubject stability. Am J Physiol Heart Circ Physiol (2002) 1.46
Prognostic value of blood pressure measured during hospitalization after acute myocardial infarction: an insight from survival trials. J Hypertens (2007) 1.44
Statistical issues of QT prolongation assessment based on linear concentration modeling. J Biopharm Stat (2008) 1.43
Enhanced presynaptic neurotransmitter release in the anterior cingulate cortex of mice with chronic pain. J Neurosci (2006) 1.43
The US Food and Drug Administration's perspective on the new antidepressant vortioxetine. J Clin Psychiatry (2015) 1.42
Assessing electrocardiographic data quality and possible replacement of pharmacologic positive control in thorough QT/QTc studies by investigations of drug-free QTc stability. Heart Rhythm (2011) 1.42
What characterizes episodes of atrial fibrillation requiring cardioversion? Experience from patients with an implantable atrial cardioverter. Am Heart J (2003) 1.41
The Wedensky test predicts malignant ventricular arrhythmias after myocardial infarction. Scand Cardiovasc J (2013) 1.39
Autonomic tests to detect cardiac risk and their clinical practicality. J Cardiovasc Electrophysiol (2011) 1.39
Baseline correction in parallel thorough QT studies. Drug Saf (2013) 1.39
Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk). Eur Heart J (2008) 1.37
Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity. Obesity (Silver Spring) (2011) 1.32
Statistical characteristics of moxifloxacin-induced QTc effect. J Biopharm Stat (2010) 1.32
Use of in vitro HTS-derived concentration-response data as biological descriptors improves the accuracy of QSAR models of in vivo toxicity. Environ Health Perspect (2010) 1.31
The sequence, structure and evolutionary features of HOTAIR in mammals. BMC Evol Biol (2011) 1.30
De novo assembly and characterization of fruit transcriptome in Litchi chinensis Sonn and analysis of differentially regulated genes in fruit in response to shading. BMC Genomics (2013) 1.30
Electromechanical analysis of infarct border zone in chronic myocardial infarction. Am J Physiol Heart Circ Physiol (2005) 1.27
Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin. Am Heart J (2004) 1.24
Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (The Autonomic Tone and Reflexes After Myocardial Infarction substudy). Am J Cardiol (2002) 1.20
Human antibody responses to avian influenza A(H7N9) virus, 2013. Emerg Infect Dis (2014) 1.19
Intermittent hypoxia has organ-specific effects on oxidative stress. Am J Physiol Regul Integr Comp Physiol (2008) 1.19
Variability of heart rate correction methods for the QT interval. Br J Clin Pharmacol (2003) 1.15
Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res (2012) 1.15
Intermittent hypoxia inhibits clearance of triglyceride-rich lipoproteins and inactivates adipose lipoprotein lipase in a mouse model of sleep apnoea. Eur Heart J (2011) 1.14
Drug induced shortening of the QT/QTc interval: an emerging safety issue warranting further modelling and evaluation in drug research and development? J Pharmacol Toxicol Methods (2008) 1.14
WU and KI polyomavirus present in the respiratory tract of children, but not in immunocompetent adults. J Clin Virol (2008) 1.12
Predicting drug-induced hepatotoxicity using QSAR and toxicogenomics approaches. Chem Res Toxicol (2011) 1.11
Mental stress and sudden cardiac death: asymmetric midbrain activity as a linking mechanism. Brain (2004) 1.11
Changes in heart rate and heart rate variability over time in middle-aged men and women in the general population (from the Whitehall II Cohort Study). Am J Cardiol (2007) 1.09
Fetal deficiency of lin28 programs life-long aberrations in growth and glucose metabolism. Stem Cells (2013) 1.09
Anti-AIDS agents 79. Design, synthesis, molecular modeling and structure-activity relationships of novel dicamphanoyl-2',2'-dimethyldihydropyranochromone (DCP) analogs as potent anti-HIV agents. Bioorg Med Chem (2010) 1.08
The heart vector, the regional information in the electrocardiogram, and QT dispersion. Am J Cardiol (2002) 1.07
Visualization of tensor fields using superquadric glyphs. Magn Reson Med (2005) 1.07
BMP signaling restricts hemato-vascular development from lateral mesoderm during somitogenesis. Development (2006) 1.07
Phase-rectified signal averaging for the detection of quasi-periodicities and the prediction of cardiovascular risk. Chaos (2007) 1.06
Characterization of QT interval adaptation to RR interval changes and its use as a risk-stratifier of arrhythmic mortality in amiodarone-treated survivors of acute myocardial infarction. IEEE Trans Biomed Eng (2004) 1.06
Association between missed early visits and mortality among patients of china national free antiretroviral treatment cohort. J Acquir Immune Defic Syndr (2012) 1.06
Heart rate variability in critical care medicine. Curr Opin Crit Care (2002) 1.05
Intermittent and sustained hypoxia induce a similar gene expression profile in human aortic endothelial cells. Physiol Genomics (2010) 1.04
Assessment of repolarization heterogeneity for prediction of mortality in cardiovascular disease: peak to the end of the T wave interval and nondipolar repolarization components. J Electrocardiol (2011) 1.03
Predicting chemical ocular toxicity using a combinatorial QSAR approach. Chem Res Toxicol (2012) 1.03
Human parainfluenza virus type 4 infection in Chinese children with lower respiratory tract infections: a comparison study. J Clin Virol (2011) 1.03
Allosteric hemoglobin assembly: diversity and similarity. J Biol Chem (2005) 1.03
Absence of a reductase, NCB5OR, causes insulin-deficient diabetes. Proc Natl Acad Sci U S A (2004) 1.03
Preventing tomorrow's sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention. Am Heart J (2008) 1.01
Differentiation of arrhythmia risk of the antibacterials moxifloxacin, erythromycin, and telithromycin based on analysis of monophasic action potential duration alternans and cardiac instability. J Pharmacol Exp Ther (2006) 1.01
Analysis of T-wave morphology from the 12-lead electrocardiogram for prediction of long-term prognosis in male US veterans. Circulation (2002) 1.01
Prognostic impact of demographic factors and clinical features on the mode of death in high-risk patients after myocardial infarction--a combined analysis from multicenter trials. Clin Cardiol (2005) 1.00
Dexmedetomidine controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Inflammation (2014) 1.00
Prevalence of human coronaviruses in adults with acute respiratory tract infections in Beijing, China. J Med Virol (2011) 1.00
Nitroglycerin induced syncope occurs in subjects with delayed phase shift of baroreflex action. Pacing Clin Electrophysiol (2002) 0.99
A network of heterochronic genes including Imp1 regulates temporal changes in stem cell properties. Elife (2013) 0.99
Antitumor agents. 280. Multidrug resistance-selective desmosdumotin B analogues. J Med Chem (2010) 0.99
Rapid conversion of persistent atrial fibrillation to sinus rhythm by intravenous AZD7009. J Clin Pharmacol (2009) 0.99
Analyses of dynamic beat-to-beat QT-TQ interval (ECG restitution) changes in humans under normal sinus rhythm and prior to an event of torsades de pointes during QT prolongation caused by sotalol. Ann Noninvasive Electrocardiol (2007) 0.98
Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo. J Cell Biochem (2012) 0.98
Genetic analysis of norovirus in children affected with acute gastroenteritis in Beijing, 2004-2007. J Clin Virol (2008) 0.97